382 related articles for article (PubMed ID: 27539645)
1. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads.
Cheng Y; Gao H; Tang L; Li J; Yao L
Echocardiography; 2016 Nov; 33(11):1689-1696. PubMed ID: 27539645
[TBL] [Abstract][Full Text] [Related]
2. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
Mediratta A; Addetia K; Yamat M; Moss JD; Nayak HM; Burke MC; Weinert L; Maffessanti F; Jeevanandam V; Mor-Avi V; Lang RM
JACC Cardiovasc Imaging; 2014 Apr; 7(4):337-47. PubMed ID: 24631508
[TBL] [Abstract][Full Text] [Related]
3. Permanent cardiac pacing and its influence on tricuspid valve function.
Krupa W; Kozłowski D; Derejko P; Swiatecka G
Folia Morphol (Warsz); 2001 Nov; 60(4):249-57. PubMed ID: 11770335
[TBL] [Abstract][Full Text] [Related]
4. Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: role of real time three-dimensional echocardiography.
Nucifora G; Badano LP; Allocca G; Gianfagna P; Proclemer A; Cinello M; Fioretti PM
Echocardiography; 2007 Jul; 24(6):649-52. PubMed ID: 17584205
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional color Doppler echocardiographic quantification of tricuspid regurgitation orifice area: comparison with conventional two-dimensional measures.
Chen TE; Kwon SH; Enriquez-Sarano M; Wong BF; Mankad SV
J Am Soc Echocardiogr; 2013 Oct; 26(10):1143-1152. PubMed ID: 23993694
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads.
Seo Y; Ishizu T; Nakajima H; Sekiguchi Y; Watanabe S; Aonuma K
Circ J; 2008 Sep; 72(9):1465-70. PubMed ID: 18724023
[TBL] [Abstract][Full Text] [Related]
7. Tricuspid Valve Dysfunction Caused by Right Ventricular Leads.
Ebrille E; Chang JD; Zimetbaum PJ
Card Electrophysiol Clin; 2018 Sep; 10(3):447-452. PubMed ID: 30172281
[TBL] [Abstract][Full Text] [Related]
8. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
Schleifer JW; Pislaru SV; Lin G; Powell BD; Espinosa R; Koestler C; Thome T; Polk L; Li Z; Asirvatham SJ; Cha YM
Heart Rhythm; 2018 Jul; 15(7):1009-1016. PubMed ID: 29496605
[TBL] [Abstract][Full Text] [Related]
9. Pacemaker-induced tricuspid regurgitation is uncommon immediately post-implantation.
Rothschild DP; Goldstein JA; Kerner N; Abbas AE; Patel M; Wong WS
J Interv Card Electrophysiol; 2017 Sep; 49(3):281-287. PubMed ID: 28685199
[TBL] [Abstract][Full Text] [Related]
10. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
[TBL] [Abstract][Full Text] [Related]
11. Impact of implantable transvenous device lead location on severity of tricuspid regurgitation.
Addetia K; Maffessanti F; Mediratta A; Yamat M; Weinert L; Moss JD; Nayak HM; Burke MC; Patel AR; Kruse E; Jeevanandam V; Mor-Avi V; Lang RM
J Am Soc Echocardiogr; 2014 Nov; 27(11):1164-75. PubMed ID: 25129393
[TBL] [Abstract][Full Text] [Related]
12. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
[TBL] [Abstract][Full Text] [Related]
13. Proximal isovelocity surface area by single-beat three-dimensional color Doppler echocardiography applied for tricuspid regurgitation quantification.
de Agustin JA; Viliani D; Vieira C; Islas F; Marcos-Alberca P; Gomez de Diego JJ; Nuñez-Gil IJ; Almeria C; Rodrigo JL; Luaces M; Garcia-Fernandez MA; Macaya C; Perez de Isla L
J Am Soc Echocardiogr; 2013 Sep; 26(9):1063-72. PubMed ID: 23860094
[TBL] [Abstract][Full Text] [Related]
14. Cardiac implantable electronic device-induced tricuspid regurgitation: Implications and management.
Murphy SP; Lew J; Yucel E; Singh J; Mela T
J Cardiovasc Electrophysiol; 2024 May; 35(5):1017-1025. PubMed ID: 38501386
[TBL] [Abstract][Full Text] [Related]
15. A new view of an unusual pacemaker complication: role of three-dimensional transthoracic echocardiography.
Miglioranza MH; Becker D; Jiménez-Nácher JJ; Moya JL; Golfin CF; Zamorano JL
Echocardiography; 2013 Jul; 30(6):E164-6. PubMed ID: 23551119
[TBL] [Abstract][Full Text] [Related]
16. Assessment of functional tricuspid regurgitation using 320-detector-row multislice computed tomography: risk factor analysis for recurrent regurgitation after tricuspid annuloplasty.
Kabasawa M; Kohno H; Ishizaka T; Ishida K; Funabashi N; Kataoka A; Matsumiya G
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):312-20. PubMed ID: 23246056
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
[TBL] [Abstract][Full Text] [Related]
18. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA
Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
[TBL] [Abstract][Full Text] [Related]
19. Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads.
Najib MQ; Vittala SS; Challa S; Raizada A; Tondato FJ; Lee HR; Chaliki HP
Tex Heart Inst J; 2013; 40(5):529-33. PubMed ID: 24391312
[TBL] [Abstract][Full Text] [Related]
20. Entrapment of permanent pacemaker lead as the cause of tricuspid regurgitation.
Chen TE; Wang CC; Chern MS; Chu JJ
Circ J; 2007 Jul; 71(7):1169-71. PubMed ID: 17587731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
